99 related articles for article (PubMed ID: 23184735)
1. How calcium inhibits the magnesium-dependent kinase gsk3β: a molecular simulation study.
Lu SY; Huang ZM; Huang WK; Liu XY; Chen YY; Shi T; Zhang J
Proteins; 2013 May; 81(5):740-53. PubMed ID: 23184735
[TBL] [Abstract][Full Text] [Related]
2. Molecular modeling and molecular dynamics simulation studies of the GSK3β/ATP/substrate complex: understanding the unique P+4 primed phosphorylation specificity for GSK3β substrates.
Lu SY; Jiang YJ; Zou JW; Wu TX
J Chem Inf Model; 2011 May; 51(5):1025-36. PubMed ID: 21495724
[TBL] [Abstract][Full Text] [Related]
3. Dissection of the difference between the group I metal ions in inhibiting GSK3β: a computational study.
Lu SY; Jiang YJ; Zou JW; Wu TX
Phys Chem Chem Phys; 2011 Apr; 13(15):7014-23. PubMed ID: 21409189
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the complete loss of GSK3beta catalytic activity due to R96 mutation investigated by molecular dynamics study.
Zhang N; Jiang Y; Zou J; Yu Q; Zhao W
Proteins; 2009 May; 75(3):671-81. PubMed ID: 19003984
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of kinase inactivation and nonbinding of FRATide to GSK3β due to K85M mutation: molecular dynamics simulation and normal mode analysis.
Lu S; Jiang Y; Lv J; Zou J; Wu T
Biopolymers; 2011 Oct; 95(10):669-81. PubMed ID: 21442609
[TBL] [Abstract][Full Text] [Related]
6. Effect of double mutations K214/A-E215/Q of FRATide on GSK3β: insights from molecular dynamics simulation and normal mode analysis.
Lu SY; Jiang YJ; Zou JW; Wu TX
Amino Acids; 2012 Jul; 43(1):267-77. PubMed ID: 21912861
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the role of Arg4 and Arg6 in the auto-inhibition mechanism of GSK3β from molecular dynamics simulation.
Mou L; Li M; Lu SY; Li S; Shen Q; Zhang J; Li C; Lu X
Chem Biol Drug Des; 2014 Jun; 83(6):721-30. PubMed ID: 24444018
[TBL] [Abstract][Full Text] [Related]
8. Homology modeling and molecular dynamics study of GSK3/SHAGGY-like kinase.
Xiao JF; Li ZS; Sun M; Zhang Y; Sun CC
Comput Biol Chem; 2004 Jul; 28(3):179-88. PubMed ID: 15261148
[TBL] [Abstract][Full Text] [Related]
9. P2 purinergic receptors signal to glycogen synthase kinase-3beta in astrocytes.
Neary JT; Kang Y
J Neurosci Res; 2006 Aug; 84(3):515-24. PubMed ID: 16810687
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
Arfeen M; Patel R; Khan T; Bharatam PV
J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
[TBL] [Abstract][Full Text] [Related]
11. Theoretical Studies on the Selectivity Mechanisms of Glycogen Synthase Kinase 3β (GSK3β) with Pyrazine ATP-competitive Inhibitors by 3DQSAR, Molecular Docking, Molecular Dynamics Simulation and Free Energy Calculations.
Zhu J; Wu Y; Xu L; Jin J
Curr Comput Aided Drug Des; 2020; 16(1):17-30. PubMed ID: 31284868
[TBL] [Abstract][Full Text] [Related]
12. Using thermodynamic integration MD simulation to compute relative protein-ligand binding free energy of a GSK3β kinase inhibitor and its analogs.
Lee HC; Hsu WC; Liu AL; Hsu CJ; Sun YC
J Mol Graph Model; 2014 Jun; 51():37-49. PubMed ID: 24858254
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta.
Aoki M; Yokota T; Sugiura I; Sasaki C; Hasegawa T; Okumura C; Ishiguro K; Kohno T; Sugio S; Matsuzaki T
Acta Crystallogr D Biol Crystallogr; 2004 Mar; 60(Pt 3):439-46. PubMed ID: 14993667
[TBL] [Abstract][Full Text] [Related]
14. Xanthone glucoside 2-β-D-glucopyranosyl-1,3,6,7-tetrahydroxy-9H-xanthen-9-one binds to the ATP-binding pocket of glycogen synthase kinase 3β and inhibits its activity: implications in prostate cancer and associated cardiovascular disease risk.
Mangangcha IR; Brojen Singh RK; Lebeche D; Ali S
J Biomol Struct Dyn; 2022 Oct; 40(17):7868-7884. PubMed ID: 33769184
[TBL] [Abstract][Full Text] [Related]
15. Microsecond molecular dynamics simulations and dynamic network analysis provide understanding of the allosteric inactivation of GSK3β induced by the L343R mutation.
Li J; Fu Q; Liang Y; Cheng B; Li X
J Mol Model; 2019 Apr; 25(5):111. PubMed ID: 30949773
[TBL] [Abstract][Full Text] [Related]
16. Effect of mutation K85R on GSK-3beta: Molecular dynamics simulation.
Sun H; Jiang YJ; Yu QS; Luo CC; Zou JW
Biochem Biophys Res Commun; 2008 Dec; 377(3):962-5. PubMed ID: 18955029
[TBL] [Abstract][Full Text] [Related]
17. Insights into unbinding mechanisms upon two mutations investigated by molecular dynamics study of GSK3beta-axin complex: role of packing hydrophobic residues.
Zhang N; Jiang Y; Zou J; Zhuang S; Jin H; Yu Q
Proteins; 2007 Jun; 67(4):941-9. PubMed ID: 17380482
[TBL] [Abstract][Full Text] [Related]
18. Detection of active fraction of glycogen synthase kinase 3beta in cancer cells by nonradioisotopic in vitro kinase assay.
Mai W; Miyashita K; Shakoori A; Zhang B; Yu ZW; Takahashi Y; Motoo Y; Kawakami K; Minamoto T
Oncology; 2006; 71(3-4):297-305. PubMed ID: 17652946
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
[TBL] [Abstract][Full Text] [Related]
20. Expression of glycogen synthase (GYS) and glycogen synthase kinase 3β (GSK3β) of the Fujian oyster, Crassostrea angulata, in relation to glycogen content in gonad development.
Zeng Z; Ni J; Ke C
Comp Biochem Physiol B Biochem Mol Biol; 2013; 166(3-4):203-14. PubMed ID: 24035883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
